Want to join the conversation?
On Sept. 9, 2015, $BIIB announced an agreement with Mitsubishi Tanabe Pharma Corp. (MTPC) to exclusively license MT-1303, a late stage experimental medicine with potential in multiple autoimmune indications. Under the terms of the agreement, $BIIB will receive worldwide rights to MT-1303, excluding Asia.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.